Published in Anemia on December 21, 2010
Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid system. Int J Biol Sci (2014) 0.96
AMPK is involved in mediation of erythropoietin influence on metabolic activity and reactive oxygen species production in white adipocytes. Int J Biochem Cell Biol (2014) 0.85
Erythropoietin Enhanced Recovery After Traumatic Nerve Injury: Myelination and Localized Effects. J Hand Surg Am (2016) 0.80
Deferoxamine Preconditioning of Neural-Like Cells Derived from Human Wharton's Jelly Mesenchymal Stem Cells as a Strategy to Promote Their Tolerance and Therapeutic Potential: An In Vitro Study. Cell Mol Neurobiol (2015) 0.77
Erythropoietin. Blood (1991) 4.37
Erythropoietin: structure, control of production, and function. Physiol Rev (1992) 4.24
Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science (2004) 4.09
Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med (2002) 3.87
Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci U S A (2004) 3.40
Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience (1997) 2.25
Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem (2005) 2.02
A mouse model for beta 0-thalassemia. Proc Natl Acad Sci U S A (1995) 2.01
Trends in anemia management among US hemodialysis patients. J Am Soc Nephrol (2002) 1.92
The hypercoagulable state in thalassemia. Blood (2002) 1.88
Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells. Cancer Res (2006) 1.80
Structural characterization of human erythropoietin. J Biol Chem (1986) 1.54
Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. Br J Haematol (2006) 1.33
Erythropoietin receptor characteristics on primary human erythroid cells. Blood (1991) 1.32
Evidence for efficient uptake and incorporation of sialic acid by eukaryotic cells. Eur J Biochem (2001) 1.32
Novel fluorescence assay using calcein-AM for the determination of human erythrocyte viability and aging. Cytometry A (2005) 1.29
A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2005) 1.24
Sickle cell disease: role of reactive oxygen and nitrogen metabolites. Clin Exp Pharmacol Physiol (2007) 1.24
Oxidative denaturation of red blood cells in thalassemia. Semin Hematol (1990) 1.24
Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochem Pharmacol (2000) 1.21
Cellular protection by erythropoietin: new therapeutic implications? J Pharmacol Exp Ther (2007) 1.20
Mechanisms and significance of eryptosis. Antioxid Redox Signal (2006) 1.20
Reactivation of fetal hemoglobin in patients with beta-thalassemia. Semin Hematol (1996) 1.18
Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin. Stroke (2005) 1.15
Superoxide-dependent and ascorbate-dependent formation of hydroxyl radicals in the presence of copper salts: a physiologically significant reaction? Arch Biochem Biophys (1983) 1.14
Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors. J Cell Physiol (1990) 1.13
Inhibition of erythrocyte cation channels by erythropoietin. J Am Soc Nephrol (2003) 1.08
Flow cytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells. Eur J Haematol (2003) 1.07
Oxygen free radicals and platelet activation. Free Radic Biol Med (1997) 1.03
Flow cytometric analysis of the oxidative status of normal and thalassemic red blood cells. Cytometry A (2004) 1.03
Erythropoietin is a multifunctional tissue-protective cytokine. Curr Hematol Rep (2003) 1.02
Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress. Biochem Biophys Res Commun (2007) 1.01
Recombinant human erythropoietin: possible role as an antioxidant in premature rabbits. Pediatr Res (1996) 1.01
Anemia management in chronic kidney disease: role of factors affecting epoetin responsiveness. J Am Soc Nephrol (2002) 1.00
Erythropoietin protects retinal pigment epithelial cells from oxidative damage. Free Radic Biol Med (2008) 0.98
Signal transducers and activators of transcription 5 contributes to erythropoietin-mediated neuroprotection against hippocampal neuronal death after transient global cerebral ischemia. Neurobiol Dis (2006) 0.97
Is erythropoietin a survival factor for red blood cells? J Am Soc Nephrol (1996) 0.96
Interaction of antioxidants and their implication in genetic anemia. Proc Soc Exp Biol Med (1999) 0.96
Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties. J Pharmacol Exp Ther (2005) 0.96
N-acetylcysteine amide (AD4) attenuates oxidative stress in beta-thalassemia blood cells. Biochim Biophys Acta (2007) 0.96
Binding of annexin V to membrane products of lipid peroxidation. Biochemistry (2001) 0.96
Protective effect of erythropoietin on beta-amyloid-induced PC12 cell death through antioxidant mechanisms. Neurosci Lett (2008) 0.93
Oxidative status of platelets in normal and thalassemic blood. Thromb Haemost (2004) 0.93
Sialic acid is an essential moiety of mucin as a hydroxyl radical scavenger. FEBS Lett (2007) 0.91
The erythropoietin receptor: biogenesis, dimerization, and intracellular signal transduction. Cold Spring Harb Symp Quant Biol (1995) 0.90
The role of recombinant human erythropoietin in the treatment of thalassemia. Ann N Y Acad Sci (1998) 0.88
Oxidative stress in patients with beta-thalassemia major. Prilozi (2007) 0.87
Increased erythrocyte phosphatidylserine exposure in chronic renal failure. J Am Soc Nephrol (1999) 0.87
Hydroxyurea and erythropoietin therapy in sickle cell anemia. Semin Oncol (1992) 0.85
Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. Acta Haematol (2004) 0.83
Erythropoietin activity in the serum of beta thalassemic patients. Scand J Haematol (1986) 0.83
Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients? Nephrol Dial Transplant (1998) 0.82
Protective effect of erythropoietin against 1-methyl-4-phenylpyridinium-induced neurodegenaration in PC12 cells. Neurosci Bull (2007) 0.82
Serum erythropoietin levels in thalassemia intermedia. Ann Hematol (1993) 0.81
Effect of erythrocyte mass on arterial blood pressure in dialysis patients receiving maintenance erythropoietin therapy. J Am Soc Nephrol (1994) 0.81
Effect of erythropoietin on the glucose transport of rat erythrocytes and bone marrow cells. Biochem Med Metab Biol (1987) 0.81
Stimulation of erythrocyte phosphatidylserine exposure by paclitaxel. Cell Physiol Biochem (2006) 0.80
The effect of erythropoietin on the cellular defence mechanism of red blood cells in children with chronic renal failure. Pediatr Nephrol (1992) 0.80
Trial of recombinant human erythropoietin: three patients with thalassemia intermedia. Blood (1992) 0.80
Sustained increase in haemoglobin and RBC following long-term administration of recombinant human erythropoietin to patients with homozygous beta-thalassaemia. Br J Haematol (1995) 0.80
Lipid peroxidation and antioxidant activity in chronic haemodialysis patients treated with recombinant human erythropoietin. Scand J Urol Nephrol (1997) 0.80
Altered sialic acid contents of red blood cell membrane preparations in homozygous beta-thalassemia. Ital J Biochem (1979) 0.79
Risks and benefits of erythropoiesis-stimulating agents in cancer management. Semin Hematol (2007) 0.79
Evaluation of red blood cell lipoperoxidation in hemodialysed patients during erythropoietin therapy supplemented or not with iron. Nephron (1995) 0.79
Oxidative status of valinomycin-resistant normal, beta-thalassemia and sickle red blood cells. Biochim Biophys Acta (2006) 0.79
Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy. J Matern Fetal Med (1999) 0.78
Effect of erythropoietin on membrane lipid peroxidation, superoxide dismutase, catalase, and glutathione peroxidase of rat RBC. Biochem Med Metab Biol (1988) 0.78
Effect of Cu(2+)-ascorbic acid on lipid peroxidation, Mg(2+)-ATPase activity and spectrin of RBC membrane and reversal by erythropoietin. Mol Cell Biochem (1992) 0.78
Uptake of sialic acid by human erythrocyte. Characterization of a transport system. Biochimie (2003) 0.78
Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants. Biochem Biophys Res Commun (2001) 0.77
Red cell lipid peroxidation and antioxidant system in haemodialysed patients: influence of recombinant human erythropoietin (r-HuEPO) treatment. Int Urol Nephrol (1998) 0.77
Effect of erythropoietin on the lipid composition of red blood cell membrane. Biochem Med (1984) 0.76
The erythrocyte membranes in beta-thalassemia. Lower sialic acid levels in glycophorin. Biochim Biophys Acta (1980) 0.76
Fetal globin stimulation during a short-term trial of erythropoietin in HbS/beta-thalassemia patients. Acta Haematol (1994) 0.76
Advances in erythropoietic growth factor therapy for myelodysplastic syndromes. Expert Opin Biol Ther (2006) 0.76
Effect of erythropoietin on the different ATPases and acetylcholinesterase of rat RBC membrane. Biochem Med Metab Biol (1986) 0.76
Measurement of total and fetal hemoglobin in cultured human erythroid cells by a novel micromethod. Hemoglobin (1993) 0.76
Effect of oxidative stress and erythropoietin on cytoskeletal protein and lipid organization in human erythrocytes. Pol J Pharmacol (1999) 0.76
Structures of mucin-type sugar chains on human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells. Arch Biochem Biophys (1993) 0.75
Identification of genes induced by interleukin-3 and erythropoietin via the Jak-Stat5 pathway using enhanced differential display-reverse southern. J Interferon Cytokine Res (1997) 0.75
Use of hydroxyurea and recombinant erythropoietin in management of homozygous beta0 thalassemia. J Pediatr Hematol Oncol (2002) 0.75
Effect of erythropoietin on the interchange of cholesterol and phospholipid between erythrocyte membrane and plasma. Biochem Med Metab Biol (1986) 0.75
Erythropoietin interaction with the mature red cell membrane. Ann N Y Acad Sci (1983) 0.75
Flow cytometry measurement of the labile iron pool in human hematopoietic cells. Cytometry A (2008) 1.59
Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. Br J Haematol (2006) 1.33
N-acetylcysteine amide, a novel cell-permeating thiol, restores cellular glutathione and protects human red blood cells from oxidative stress. Free Radic Biol Med (2005) 1.20
Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes. Haematologica (2010) 1.19
Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome. Eur J Haematol (2007) 1.18
Macrophages function as a ferritin iron source for cultured human erythroid precursors. J Cell Biochem (2008) 1.10
Flow cytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells. Eur J Haematol (2003) 1.07
Medicinal chemistry of fetal hemoglobin inducers for treatment of beta-thalassemia. Curr Med Chem (2007) 1.07
Cellular copper content modulates differentiation and self-renewal in cultures of cord blood-derived CD34+ cells. Br J Haematol (2002) 1.06
Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice. Exp Hematol (2004) 1.06
Chelatable cellular copper modulates differentiation and self-renewal of cord blood-derived hematopoietic progenitor cells. Exp Hematol (2005) 1.06
Hypoxia alters progression of the erythroid program. Exp Hematol (2007) 1.04
Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron. Eur J Haematol (2012) 1.04
Fine tuning of globin gene expression by DNA methylation. PLoS One (2006) 1.04
Flow cytometric analysis of the oxidative status of normal and thalassemic red blood cells. Cytometry A (2004) 1.03
Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftment. Exp Hematol (2011) 1.03
Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients. PLoS One (2012) 0.99
N-acetylcysteine amide (AD4) attenuates oxidative stress in beta-thalassemia blood cells. Biochim Biophys Acta (2007) 0.96
Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin. Eur J Haematol (2003) 0.94
Oxidative status of platelets in normal and thalassemic blood. Thromb Haemost (2004) 0.93
Successful transplantation of haploidentically mismatched peripheral blood stem cells using CD133+-purified stem cells. Exp Hematol (2005) 0.92
Synthetic, non-natural sphingolipid analogs inhibit the biosynthesis of cellular sphingolipids, elevate ceramide and induce apoptotic cell death. Biochim Biophys Acta (2003) 0.91
The labile iron pool in human erythroid cells. Br J Haematol (2008) 0.90
Peroxiredoxin II is essential for preventing hemolytic anemia from oxidative stress through maintaining hemoglobin stability. Biochem Biophys Res Commun (2012) 0.90
Treatment of chronic myeloid leukemia cells with imatinib (STI571) impairs p53 accumulation in response to DNA damage. Cell Cycle (2004) 0.89
Oxidative stress causes membrane phospholipid rearrangement and shedding from RBC membranes--an NMR study. Biochim Biophys Acta (2008) 0.89
Influence of lineage-specific cytokines on commitment and asymmetric cell division of haematopoietic progenitor cells. Br J Haematol (2002) 0.88
Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndrome. Br J Haematol (2011) 0.87
Rapamycin-mediated induction of gamma-globin mRNA accumulation in human erythroid cells. Br J Haematol (2004) 0.87
Physiologically aged red blood cells undergo erythrophagocytosis in vivo but not in vitro. Haematologica (2012) 0.87
The oxidative status of blood cells in a murine model of graft-versus-host disease. Ann Hematol (2007) 0.85
An electronic infrastructure for research and treatment of the thalassemias and other hemoglobinopathies: the Euro-mediterranean ITHANET project. Hemoglobin (2009) 0.85
A preclinical approach for gene therapy of beta-thalassemia. Ann N Y Acad Sci (2010) 0.84
Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation. Leuk Lymphoma (2003) 0.84
Effect of iron chelators on labile iron and oxidative status of thalassaemic erythroid cells. Acta Haematol (2009) 0.83
Are postnatal hemangioblasts generated by dedifferentiation from committed hematopoietic stem cells? Exp Hematol (2007) 0.83
Hydroxyurea exerts bi-modal dose-dependent effects on erythropoiesis in human cultured erythroid cells via distinct pathways. Br J Haematol (2002) 0.82
Fermented papaya preparation as redox regulator in blood cells of beta-thalassemic mice and patients. Phytother Res (2008) 0.82
Transferrin-iron routing to the cytosol and mitochondria as studied by live and real-time fluorescence. Biochem J (2010) 0.82
Iron-chelator complexes as iron sources for early developing human erythroid precursors. Transl Res (2007) 0.81
Oxidative stress-induced membrane shedding from RBCs is Ca flux-mediated and affects membrane lipid composition. J Membr Biol (2011) 0.81
Chronic oxidative stress reduces the respiratory burst response of neutrophils from beta-thalassaemia patients. Br J Haematol (2005) 0.81
Induction of gamma-globin gene expression by tallimustine analogs in human erythroid cells. Haematologica (2003) 0.81
Oxidative status of red blood cells, neutrophils, and platelets in paroxysmal nocturnal hemoglobinuria. Exp Hematol (2008) 0.80
Flow cytometric analysis of hydroxyurea effects on fetal hemoglobin production in cultures of beta-thalassemia erythroid precursors. Hemoglobin (2003) 0.80
Oxidative status of valinomycin-resistant normal, beta-thalassemia and sickle red blood cells. Biochim Biophys Acta (2006) 0.79
A flow cytometry approach for quantitative analysis of cellular phosphatidylserine distribution and shedding. Anal Biochem (2009) 0.79
The effect of the copper chelator tetraethylenepentamine on reactive oxygen species generation by human hematopoietic progenitor cells. Stem Cells Dev (2007) 0.79
Hemoglobin switch in the newborn: a flow cytometry analysis. Neonatology (2006) 0.78
Functional hypersplenism in mice induced by adoptive transfer of syngeneic spleen cells. Exp Biol Med (Maywood) (2006) 0.77
Retinoic acid receptor antagonist inhibits CD38 antigen expression on human hematopoietic cells in vitro. Leuk Lymphoma (2004) 0.77
Shedding of phosphatidylserine from developing erythroid cells involves microtubule depolymerization and affects membrane lipid composition. J Membr Biol (2012) 0.77
Prevalence of iron deficiency and anemia among strenuously trained adolescents. J Adolesc Health (2005) 0.77
Distribution and shedding of the membrane phosphatidylserine during maturation and aging of erythroid cells. Biochim Biophys Acta (2011) 0.76
Oxidative stress contributes to hemolysis in patients with hereditary spherocytosis and can be ameliorated by fermented papaya preparation. Ann Hematol (2010) 0.76
Heterogeneity of F cells in β-thalassemia. Transfusion (2012) 0.76
Vanadate elevates fetal hemoglobin in human erythroid precursors by inhibiting cell maturation. Exp Biol Med (Maywood) (2007) 0.76
Thalassemic DNA-Containing Red Blood Cells Are under Oxidative Stress. Anemia (2012) 0.76
Decreased hemolysis following administration of antioxidant-fermented papaya preparation (FPP) to a patient with PNH. Ann Hematol (2009) 0.76
Uptake of non-transferrin iron by erythroid cells. Anemia (2010) 0.76
Incidence of anemia and iron deficiency in strenuously trained adolescents: results of a longitudinal follow-up study. J Adolesc Health (2009) 0.75
The effect of tetraethylenepentamine, a synthetic copper chelating polyamine, on expression of CD34 and CD38 antigens on normal and leukemic hematopoietic cells. Leuk Lymphoma (2004) 0.75
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: induction of production of fetal hemoglobin in human erythroid precursor cells. Int J Mol Med (2009) 0.75
Severe fetomaternal hemorrhage confirmed and quantified by flow cytometry using anti fetal hemoglobin antibodies. Acta Obstet Gynecol Scand (2002) 0.75
Apheresis induces oxidative stress in blood cells. Ther Apher Dial (2010) 0.75